Vimarsana
Biggest News Aggregation in the World

Page 41 - Inducement Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Plan Today - Breaking & Trending Today

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported the grant of stock options to purchase an aggregate of 469,000 shares of common stock...

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Nachrichtenquelle: globenewswire  |  03.07.2021, 01:30  |  75   |  0  RESEARCH TRIANGLE PARK, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for an aggregate of 80,400 shares of G1’s common stock to eight employees under the G1 Therapeutics, Inc. 2021...

G1 Therapeutics Announces Inducement Grants Under Nasdaq - Vimarsana News

G1 Therapeutics Announces Inducement Grants Under Nasdaq

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 02, 2021 19:30 ET | Source: G1 Therapeutics G1 Therapeutics Research Triangle Park, North Carolina, UNITED STATES RESEARCH TRIANGLE PARK, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for an aggregate of 80,400 shares of G1’s common stock to eight employees under the G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (t...

Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) News provided by Share this article Share this article FREMONT, Calif. and WALTHAM, Mass., April 16, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, today announced that on April 12, 2021, the compensation committee of the Company's Board of Directors granted a non-qualified stock option award to purchase 125,622 shares of its common stock and a restricted stock u...

Pacific Biosciences Grants Equity Incentive Awards to New Employees - Vimarsana News

Pacific Biosciences Grants Equity Incentive Awards to New Employees

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Pacific Biosciences Grants Equity Incentive Awards to New Employees Pacific Biosciences of California, Inc.January 12, 2021 GMT MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options covering an aggregate of 750,000 shares of Pacific Biosciences common...

Source: apnews.com